AMRI Opens Research Centre in Hungary

US pharmaceutical company AMRI opened its research center in Budapest on June 24, the company announced.
The center reportedly cost several million USD.

CEO of AMRI's Hungarian unit, AMRI Hungary, Philip Small and the parent company's Deputy CEO Michael Trova said the facility in Budapest is the US firm's center for Europe.
The Hungarian unit offers R+D services and sells pre-prepared molecules for western European, US and Hungarian pharmaceutical companies involved in the early stages of pharmaceutical development.

News Monitoring